Imunon, Inc.
IMNN
$3.96
$0.051.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -6.01M | -6.01M | -4.42M | -3.29M | -1.62M |
| Gross Profit | 6.01M | 6.01M | 4.42M | 3.29M | 1.62M |
| SG&A Expenses | 7.01M | 7.10M | 7.76M | 7.49M | 7.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.54M | 16.02M | 18.27M | 19.13M | 20.95M |
| Operating Income | -14.54M | -16.02M | -18.27M | -19.13M | -20.95M |
| Income Before Tax | -14.33M | -15.75M | -17.79M | -18.62M | -20.73M |
| Income Tax Expenses | -- | -- | -- | -- | -1.28M |
| Earnings from Continuing Operations | -14.33 | -15.75 | -17.79 | -18.62 | -19.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.33M | -15.75M | -17.79M | -18.62M | -19.45M |
| EBIT | -14.54M | -16.02M | -18.27M | -19.13M | -20.95M |
| EBITDA | -14.28M | -15.78M | -18.03M | -18.89M | -20.68M |
| EPS Basic | -10.35 | -12.94 | -17.72 | -20.88 | -24.02 |
| Normalized Basic EPS | -6.47 | -8.09 | -11.07 | -13.05 | -16.12 |
| EPS Diluted | -10.35 | -12.94 | -17.72 | -20.88 | -24.02 |
| Normalized Diluted EPS | -6.47 | -8.09 | -11.07 | -13.05 | -16.12 |
| Average Basic Shares Outstanding | 6.64M | 4.99M | 4.24M | 3.84M | 3.45M |
| Average Diluted Shares Outstanding | 6.64M | 4.99M | 4.24M | 3.84M | 3.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |